REGULUS THERAPEUTICS INC - COM (RGLS)

Historical Holders from Q1 2014 to Q2 2025

Type / Class
Equity / COM
Symbol
RGLS on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of REGULUS THERAPEUTICS INC - COM (RGLS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q2 0 $0 -$1,677,104 0
2025 Q1 958,345 $1,677,104 +$1,677,104 175% 1
2018 Q4 0 $0 -$4,785,396 0
2018 Q3 25,272,300 $4,992,397 -$3,527,313 19.77% 27
2018 Q2 51,917,067 $34,225,221 -$818,958 65.94% 43
2018 Q1 53,117,675 $38,114,583 -$2,752,049 71.77% 47
2017 Q4 55,902,880 $58,140,292 -$7,356,863 104% 44
2017 Q3 61,731,498 $77,164,255 +$48,990,440 125% 46
2017 Q2 22,742,204 $22,414,201 +$2,052,366 98.57% 43
2017 Q1 20,046,186 $33,069,893 -$6,099,276 164.99% 57
2016 Q4 23,510,264 $52,895,427 -$9,137,146 225% 67
2016 Q3 26,490,162 $87,413,081 -$2,110,119 329.99% 81
2016 Q2 27,241,523 $78,716,473 -$54,779,490 288.94% 82
2016 Q1 34,279,240 $237,474,256 -$774,096 693% 99
2015 Q4 34,262,000 $298,845,791 -$7,416,860 871.99% 104
2015 Q3 34,556,119 $225,977,437 -$2,210,402 654% 89
2015 Q2 34,374,718 $376,688,473 +$12,875,964 1,095.98% 91
2015 Q1 32,776,654 $555,323,816 +$57,107,092 1,693.98% 88
2014 Q4 29,514,732 $473,541,778 +$243,224,335 1,603.93% 81
2014 Q3 14,576,363 $99,558,167 +$1,866,359 683.02% 48
2014 Q2 14,281,420 $114,811,487 +$428,433 804% 52
2014 Q1 14,194,162 $127,948,008 -$4,963,098 901.97% 54